These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 32548871)

  • 21. Glycaemic control after treatment intensification in patients with type 2 diabetes uncontrolled on two or more non-insulin antidiabetic drugs in a real-world setting.
    Canivell S; Mata-Cases M; Real J; Franch-Nadal J; Vlacho B; Khunti K; Gratacòs M; Mauricio D
    Diabetes Obes Metab; 2019 Jun; 21(6):1373-1380. PubMed ID: 30756446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical inertia in basal insulin-treated patients with type 2 diabetes - Results from a retrospective database study in Japan (JDDM 43).
    Satoh J; Andersen M; Bekker Hansen B; Larsen Thorsted B; Tutkunkardas D; Zacho M; Maegawa H
    PLoS One; 2018; 13(9):e0198160. PubMed ID: 30226870
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical pharmacist intervention and the proportion of diabetes patients attaining prevention objectives in a multispecialty medical group.
    Padiyara RS; D'Souza JJ; Rihani RS
    J Manag Care Pharm; 2011; 17(6):456-62. PubMed ID: 21787031
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of Clinical Pharmacist Intervention on Hemoglobin A1C Reduction in Veteran Patients With Type 2 Diabetes in a Rural Setting.
    Sullivan J; Jett BP; Cradick M; Zuber J
    Ann Pharmacother; 2016 Dec; 50(12):1023-1027. PubMed ID: 27497068
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of Pharmacist-Driven Professional Continuous Glucose Monitoring in Adults with Uncontrolled Diabetes.
    Sherrill CH; Houpt CT; Dixon EM; Richter SJ
    J Manag Care Spec Pharm; 2020 May; 26(5):600-609. PubMed ID: 32347180
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of pharmacist consults within a collaborative enhanced primary care team model to improve diabetes care.
    Firkus D; McCoy RG; Matulis J; Kessler M; Mara K; Herges J
    PLoS One; 2023; 18(1):e0280654. PubMed ID: 36662741
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary care-based, pharmacist-physician collaborative medication-therapy management of hypertension: a randomized, pragmatic trial.
    Hirsch JD; Steers N; Adler DS; Kuo GM; Morello CM; Lang M; Singh RF; Wood Y; Kaplan RM; Mangione CM
    Clin Ther; 2014 Sep; 36(9):1244-54. PubMed ID: 25085406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacist recommendations to improve the quality of diabetes care: a randomized controlled trial.
    Kirwin JL; Cunningham RJ; Sequist TD
    J Manag Care Pharm; 2010 Mar; 16(2):104-13. PubMed ID: 20178395
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A retrospective cohort analysis of the clinical effectiveness of a physician-pharmacist collaborative drug therapy management diabetes clinic.
    Irons BK; Lenz RJ; Anderson SL; Wharton BL; Habeger B; Anderson HG
    Pharmacotherapy; 2002 Oct; 22(10):1294-300. PubMed ID: 12389879
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Longitudinal changes in glycated haemoglobin following treatment intensification after inadequate response to two oral antidiabetic agents in patients with type 2 diabetes.
    Kim K; Unni S; Brixner DI; Thomas SM; Olsen CJ; Sterling KL; Mitchell M; McAdam-Marx C
    Diabetes Obes Metab; 2019 Jul; 21(7):1725-1733. PubMed ID: 30848039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DOES CLINICAL INERTIA VARY BY PERSONALIZED A1C GOAL? A STUDY OF PREDICTORS AND PREVALENCE OF CLINICAL INERTIA IN A U.S. MANAGED-CARE SETTING.
    Lin J; Zhou S; Wei W; Pan C; Lingohr-Smith M; Levin P
    Endocr Pract; 2016 Feb; 22(2):151-61. PubMed ID: 26492540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patient and Provider Factors Affecting Clinical Inertia in Patients With Type 2 Diabetes on Metformin Monotherapy.
    Mahabaleshwarkar R; Gohs F; Mulder H; Wilkins N; DeSantis A; Anderson WE; Ejzykowicz F; Rajpathak S; Norton HJ
    Clin Ther; 2017 Aug; 39(8):1658-1670.e6. PubMed ID: 28689692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A pharmacist-managed cardiovascular risk-reduction clinic for individuals experiencing serious mental illness.
    Gonzalvo JD; Hamm JA; Shan M
    J Am Pharm Assoc (2003); 2019; 59(5):698-703. PubMed ID: 31324536
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized controlled trial of clinical pharmacy management of patients with type 2 diabetes in an outpatient diabetes clinic in Jordan.
    Jarab AS; Alqudah SG; Mukattash TL; Shattat G; Al-Qirim T
    J Manag Care Pharm; 2012 Sep; 18(7):516-26. PubMed ID: 22971205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved Glycemic Control With Minimal Change in Medication Regimen Complexity in a Pharmacist-Endocrinologist Diabetes Intense Medical Management (DIMM) "Tune Up" Clinic.
    Morello CM; Rotunno T; Khoan J; Hirsch JD
    Ann Pharmacother; 2018 Nov; 52(11):1091-1097. PubMed ID: 29775079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of Glycemic Control of a Pharmacist-Led Medication Management Program in Patients with Type 2 Diabetes.
    Ko JJ; Lu J; Rascati K; Stock EM; Juan J; Suh K; Kim Y; Tabor PA; Godley PJ
    J Manag Care Spec Pharm; 2016 Jan; 22(1):32-7. PubMed ID: 27015049
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Centrally supported clinical pharmacist intervention to reduce clinical inertia in hypertension.
    Lowe RN; Kovac N; Lobo I; Billups SJ
    Am J Health Syst Pharm; 2023 Mar; 80(7):457-461. PubMed ID: 36480345
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implementation of a pharmacist-supervised outpatient diabetes treatment clinic.
    Collier IA; Baker DM
    Am J Health Syst Pharm; 2014 Jan; 71(1):27-36. PubMed ID: 24352179
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacist-led, primary care-based disease management improves hemoglobin A1c in high-risk patients with diabetes.
    Rothman R; Malone R; Bryant B; Horlen C; Pignone M
    Am J Med Qual; 2003; 18(2):51-8. PubMed ID: 12710553
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment intensification for patients with type 2 diabetes and poor glycaemic control.
    Fu AZ; Sheehan JJ
    Diabetes Obes Metab; 2016 Sep; 18(9):892-8. PubMed ID: 27160505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.